EA201991993A1 - Применение фенилкреатина в качестве ноотропного агента - Google Patents

Применение фенилкреатина в качестве ноотропного агента

Info

Publication number
EA201991993A1
EA201991993A1 EA201991993A EA201991993A EA201991993A1 EA 201991993 A1 EA201991993 A1 EA 201991993A1 EA 201991993 A EA201991993 A EA 201991993A EA 201991993 A EA201991993 A EA 201991993A EA 201991993 A1 EA201991993 A1 EA 201991993A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenylcreatin
application
nootropic agent
nootropic
agent
Prior art date
Application number
EA201991993A
Other languages
English (en)
Other versions
EA037841B1 (ru
Inventor
Илья Владимирович ДУХОВЛИНОВ
Original Assignee
Алексеев, Алексей Викторович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алексеев, Алексей Викторович filed Critical Алексеев, Алексей Викторович
Priority to EA201991993A priority Critical patent/EA037841B1/ru
Publication of EA201991993A1 publication Critical patent/EA201991993A1/ru
Publication of EA037841B1 publication Critical patent/EA037841B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области фармацевтической химии. В частности, изобретение относится к применению фенилкреатина в качестве ноотропного агента.
EA201991993A 2017-01-20 2017-01-20 Применение фенилкреатина в качестве ноотропного агента EA037841B1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201991993A EA037841B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина в качестве ноотропного агента

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201991993A EA037841B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина в качестве ноотропного агента

Publications (2)

Publication Number Publication Date
EA201991993A1 true EA201991993A1 (ru) 2020-01-15
EA037841B1 EA037841B1 (ru) 2021-05-26

Family

ID=69374518

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991993A EA037841B1 (ru) 2017-01-20 2017-01-20 Применение фенилкреатина в качестве ноотропного агента

Country Status (1)

Country Link
EA (1) EA037841B1 (ru)

Also Published As

Publication number Publication date
EA037841B1 (ru) 2021-05-26

Similar Documents

Publication Publication Date Title
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
EA202092435A3 (ru) Моноклональные антитела против bcma
EA201890204A1 (ru) Антибактериальные соединения
EA201891211A1 (ru) Ингибиторы cxcr2
EA201691991A1 (ru) Мультиспецифические антитела
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201992177A1 (ru) Композиции на основе нирапариба
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
EA201790785A1 (ru) Производные тетрагидроизохинолина
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201790380A1 (ru) Ингибиторы mk2 и их применения
EA201890810A1 (ru) Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
TR201910057T4 (tr) Kauçuk bi̇leşi̇mleri̇
EA201791174A1 (ru) Антимикотическое соединение
EA201892822A1 (ru) Новые антибактериальные соединения
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
TR201902741T4 (tr) Kişisel Temizlik Bileşimleri
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EA201790410A1 (ru) Содержащая цинеол композиция для назального применения
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
TR201901228T4 (tr) Vortioksetin piroglutamat.
EA201790156A1 (ru) Азетидинилоксифенилпирролидиновые соединения
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
BR112017011285A2 (pt) compostos intermediários para produzir ingredientes de perfumaria